MIGDEN, M.; RISCHIN, D.; SASANE, M.; MASTEY, V.; PAVLICK, A.; SCHMULTS, C.; CHEN, Z.; GUMINSKI, A.; HAUSCHILD, A.; BURY, D.; HUDGENS, S.; CHANG, A. L.; RABINOWITS, G.; IBRAHIM, S.; FURY, M.; LOWY, I.; LI, S.; CHEN, C.-I. Cemiplimab Improves Health-Related Quality of Life (HRQoL) and Reduces Pain in Patients with Advanced Cutaneous Squamous Cell Carcinoma (CSCC): Results from a Post Hoc Exploratory Analysis of a Phase 2 Clinical Trial. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 5, n. 1, p. s5, 2021. DOI: 10.25251/skin.5.supp.5. Disponível em: https://jofskin.org/index.php/skin/article/view/1157. Acesso em: 3 jul. 2024.